Answers are grounded in this paper and cite their sources.
Background: Intra-coronary injection of Autologous Bone Marrow-Stem Cells (ABMSC) has been demonstrated to improve Left Ventricular (LV) function after acute ST Elevation Myocardial Infarction (STEMI). After analyzing the safety and feasibility of this treatment, long term durability of the treatment effect is needed to be analyzed. The aim of the present study was to analyze the ventricular remodeling by LV function and clinical effects of patients undergone ABMSCs therapy following Acute Myocardial Infarction (AMI) at 24 months.
No takes yet. Share an insight, caveat, or question.
Vinod K. Shah (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: